Loading...
Market
Number of new AI tools presented at ASCO 2025?
5
Resolution / Starting Odds
1 to 3 new AI tools • 33%
4 to 6 new AI tools • 33%
More than 6 new AI tools • 33%
Official ASCO 2025 conference reports or announcements
Story
AI Tools at ASCO 2024: MyEleanor Re-engages 57% of Missed Colonoscopy Patients
Jun 2, 2024, 02:58 AM
At the ASCO 2024 conference, several studies highlighted the effectiveness of artificial intelligence (AI) tools in oncology. AI virtual navigation tools were shown to be highly effective in re-engaging patients who missed their colonoscopy appointments. At Montefiore Medical Center in the Bronx, the AI tool MyEleanor was used to contact patients who had canceled or missed their appointments. The tool successfully re-engaged 57% of the 2400 patients contacted, with over half of those agreeing to reschedule their appointments. This AI-driven approach aims to address the issue of nonadherence to cancer screening appointments, ultimately improving patient outcomes.
View original story
Similar markets
Advanced AI functionalities • 25%
Improved user interface • 25%
Enhanced data security features • 25%
Integration with other software services • 25%
0 products • 33%
1 to 2 products • 33%
3 or more products • 34%
1-2 features • 25%
3-4 features • 25%
5-6 features • 25%
More than 6 features • 25%
Tool 1 • 10%
Tool 2 • 10%
Tool 3 • 10%
Tool 4 • 10%
Tool 5 • 10%
Tool 6 • 10%
Tool 7 • 10%
Tool 8 • 10%
Tool 9 • 10%
Tool 10 • 10%
Added 5+ new languages • 25%
Added 3-4 new languages • 25%
Added 1-2 new languages • 25%
No new languages added • 25%
Yes, new major AI tool released • 50%
No, no new major AI tool released • 50%
0-2 projects • 25%
3-5 projects • 25%
6-8 projects • 25%
More than 8 projects • 25%
None • 25%
1-2 applications • 25%
3-5 applications • 25%
More than 5 applications • 25%